American Society of Hematology

ASH is the leader in representing the interests of scientists and clinicians working in the field of hematology on Capitol Hill and within federal agencies concerned with the study and treatment of blood-related diseases.

View all action alerts
  • What Hematologist Need to Know about the Medicare Merit-based Incentive Payment System

    In April, 2015, the Medicare Access and CHIP Reauthorization (MACRA) was signed into law by the President. The headline at the time of passage was the end of the Sustainable Growth Rate (SGR) formula that had for so many years mandated large annual Medicare payment cuts to physicians. This calculated approach was replaced with a fixed payment update of 0.5% per year from 2016-2019, followed by flat payment rates for five years. However, MACRA did not just affect the overall payment mechanism – it also created a new pay for performance system for physicians. Many of these elements are similar or identical to the existing pay-for-performance program in Medicare but we will highlight some of the differences.

  • 2015 ASH Advocacy Efforts Related to Sickle Cell Disease and Sickle Cell Trait

    ASH is committed to addressing the burden of sickle cell disease (SCD) worldwide and continues to work with various groups in the sickle cell stakeholder community, Congress, the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and other federal agencies to increase research, treatment options, and access to care for patients with SCD. The Society has also taken a number of steps to increase education and awareness about sickle cell trait (SCT).

  • 2015 ASH Advocacy Efforts to Ensure Access to Safe and Effective Hematologic Drugs

    During 2015, ASH made many advocacy efforts to ensure access to safe and effective hematologic drugs.

  • 2015 Physician Payment Advocacy Highlights

    During 2015, ASH made numerous advocacy efforts related to physician payment policies.

View all policy news
back to top